1. Home
  2. MSC vs ABOS Comparison

MSC vs ABOS Comparison

Compare MSC & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Studio City International Holdings Limited

MSC

Studio City International Holdings Limited

SELL

Current Price

$1.12

Market Cap

188.9M

ML Signal

SELL

Logo Acumen Pharmaceuticals Inc.

ABOS

Acumen Pharmaceuticals Inc.

HOLD

Current Price

$0.18

Market Cap

165.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MSC
ABOS
Founded
2000
1996
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
188.9M
165.6M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
MSC
ABOS
Price
$1.12
$0.18
Analyst Decision
Hold
Analyst Count
0
6
Target Price
N/A
★ $1.00
AVG Volume (30 Days)
72.1K
★ 5.6M
Earning Date
11-04-2026
10-26-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.76
$0.17
52 Week High
$4.19
$3.60

Technical Indicators

Market Signals
Indicator
MSC
ABOS
Relative Strength Index (RSI) 60.35 21.27
Support Level $0.77 N/A
Resistance Level $1.31 $2.82
Average True Range (ATR) 0.15 0.02
MACD 0.03 0.03
Stochastic Oscillator 66.65 24.00

Price Performance

Historical Comparison
MSC
ABOS

About MSC Studio City International Holdings Limited

Studio City International Holdings Ltd is a gaming, retail, and entertainment resort located in Cotai, Macau. It operates Studio City Casino with around 250 mass-market gaming tables; including tables for VIP rolling chip operations, and 552 gaming machines. Studio City features luxury hotel rooms, diverse food and beverage establishments, and complementary retail space. In addition, the company offers non-gaming attractions, including the world's first figure-8 Ferris wheel, a deluxe nightclub and karaoke venue, a live performance arena, an outdoor and an indoor water park. Geographically, the company derives the majority of its revenue from the Macau region.

About ABOS Acumen Pharmaceuticals Inc.

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.

Share on Social Networks: